Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 6
77
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects

, , , , , , , , , , & show all
Pages 625-641 | Published online: 22 Sep 2008

References

  • BRODIE, R., PEARD, A., ROTH, A., PERSIANI, S., MAKOVEC, F. and D'AmATo, M., 2003, Development and validation of a bioanalytical method for the determination of the cholecystokinin type-1 (CCI(i) receptor antagonist dexloxiglumide in human plasma. Journal of Chromatography B, 784, 91–100.
  • D'AmATo, M., MAKOVEC, F. and ROVATI, L. C., 1999b, CCKA-receptors in gastrointestinal disorders. In T. S. Gaginella and A. Guglietta (eds), Drug Development: Molecular Targets for GI Diseases (Totowa: Human Press), pp. 147–175.
  • D'AmATo, M., WHORWELL, P. J., THOMPSON, D. G., SPILLER, R. C., GIACOVELLI, G. and ROVATI, L. C., 1999a, The efficacy and safety of the CCKA-receptor antagonist dexloxiglumide in IBS. Gut, 45 (Suppl. V), A258.
  • D'AmATo, M., WHORWELL, P. J., THOMPSON, D. G., SPILLER, R. C., GIACOVELLI, G., GRIFFIN, P. H., SCHNEIER, H. and ROVATI, L. C., 2001, CCKi-receptor antagonist dexloxiglumide is effective and safe in female patients with constipation predominant irritable bowel syndrome. American Journal of Gastroenterology, 96, S317.
  • DAVIES, B. and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 10, 1093–1095.
  • FEINLE, C., MEIER, O. and D'AmATo, M., 1999, CCK-A Receptor blockade improves dyspeptic symptoms due to duodenal lipid and gastric distension in functional dyspepsia. Gastroenterology, 116 (Suppl.), A992.
  • FIESER, L. F. and FIESER, M., 1956, Organic Chemistry (New York: Reinhold).
  • FIORAMONTI, J., D'AMATO, M., ROVATI, L. and ButNo, L., 1996, Effects of dexloxiglumide on gastric emptying delayed by colonic distension in dogs. Neurogastroenterology and Motility, 8, 172.
  • GIBSON, G. G. and SKETT, P., 1986, Introduction to Drug Metabolism (London: Chapman & Hall). GRIDER, J. R., 1994, Role of cholecystokinin in the regulation of gastrointestinal motility. Journal of Nutrition, 124 (Suppl. 8), 1334S–1339S.
  • HALL, M., CHEUNG, Y.L., MATTHEWS, A., HOLDING, J. D., CYBULSKI, Z. R., PERSIAN', S., D'AMATO, M. and MAKOVEC, F., 2001, Phase I metabolism of dexloxiglumide (CR 2017) by human liver microsomes. Drug Metabolism Reviews, 33 (Suppl. 1), 91.
  • HIROM, P. C., IDLE, J. R. and MILLBURN, P., 1977, Comparative aspects of the biosynthesis and excretion of xenobiotic conjugates by non-primate mammals. In D. V. Parke and R. L. Smith (eds), Drug Metabolism — From Microbe to Man (London: Taylor & Francis), pp. 299–329.
  • MEIER, R., BEGLINGER, C., GIACOVELLI, G. and D'AMATO, M., 1997, Effect of the CCK-A receptor antagonist dexloxiglumide on postprandial gallbladder emptying and colonic transit time in healthy volunteers, Gastroenterology, 112, A788.
  • PERSIAN', S., D'AMATO, M., MAKOVEC, F., TAVARES, I. A., BISHAI, P. M. and ROVATI, L. C., 2002, Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males. International Journal of Clinical Pharmacology and Therapeutics, 40, 108–206.
  • REVEL, L., MAKOVEC, F. and CASTANER, J., 1999, Dexloxiglumide — CCKi (CCKA) receptor antagonist treatment of irritable bowel syndrome. Drugs of the Future, 24, 725–728.
  • ROUZADE, M. L. FIORAMONTI, J., D'AMATO, M., ROVATI, L. and ButNo, L., 1996, Inhibitory action of dexloxiglumide on transient lower oesophageal sphincter relaxation in dogs. Neurogastroenter-ology and Motility, 8, 188.
  • SCARPIGNATO, C., KISFALV I., D'AMATO, M. and VARGA, G., 1996, Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo. Alimentary Pharmacology Therapy, 10, 411–419.
  • SCHELINE, R. R., 1973, Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacological Reviews, 25, 451–523.
  • WOODRUFF, G. N. and HUGHES, J., 1991, Cholecystokinin antagonists. Annual Review of Pharmacology and Toxicology, 31, 469–501.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.